Newfound Research 13F Filed Apr 16, 2026

Context

Newfound Research LLC submitted a Form 13F filing to the SEC that was publicly reported on April 16, 2026, disclosing its long holdings as of March 31, 2026 (SEC EDGAR; Investing.com, Apr 16, 2026). The 13F framework requires institutional managers with more than $100 million in qualifying securities to report their positions within 45 days of quarter-end; this particular filing arrived 16 days after quarter-end, materially earlier than the 45-day statutory deadline (SEC.gov). That timing is a factual data point that market analysts frequently use as a proxy for operational capacity to compile and disclose position-level data quickly. While the raw 13F does not contain intraday or short positions, it is a concrete snapshot of equity exposures at the quarter's close and therefore useful for comparative analysis and signal mining.

Form 13F disclosures are inherently lagged: the numbers represent positions held on March 31, 2026, rather than the filing date on April 16, 2026. That lag means any tactical moves made after quarter-end do not appear until the next report and can cause misinterpretation when investors conflate filing date with contemporaneous positioning. For institutional investors and allocators, the combination of filing-date timing, position concentration, and turnover metrics in sequential 13F filings is more informative than any single disclosure. This article uses the April 16, 2026 filing as a case study in how to read a boutique quantitative manager's 13F for signs of strategy drift, concentration risk, and ETF usage.

The Investing.com summary published on Apr 16, 2026 provides a headline for the filing but omits granular context that institutional readers require, such as turnover and weighting changes vs prior quarters (Investing.com, Apr 16, 2026). For deeper parsing readers should consult the SEC EDGAR XML/CSV output for the filing (SEC EDGAR search: Newfound Research LLC Form 13F, filed Apr 16, 2026). This article therefore synthesizes the filing mechanics, timing, and the interpretive framework institutional investors should apply when integrating small-manager 13Fs into allocations or research pipelines. For methodological background on using regulatory filings in investment research see our research portal topic.

Data Deep Dive

The foundational, verifiable datapoints in this filing sequence are straightforward: the report was filed on April 16, 2026; it reports positions as of March 31, 2026; and it was submitted 16 calendar days after the quarter end (SEC EDGAR; Investing.com). These three numeric facts anchor any downstream inference. The statutory filing window of 45 days implies a latest permissible filing date of May 15, 2026 for quarter-end reporting — Newfound filed well within that window. Quick filing can indicate internal reporting efficiency or a deliberate disclosure cadence, but it is not on its own evidence of a particular directional bet.

Institutional readers should combine the 13F snapshot with sequential change metrics. A basic analytical workflow is to compute quarter-over-quarter (QoQ) and year-over-year (YoY) position-weight changes for each security listed, compare aggregate sector weight shifts, and flag concentration ratios such as the top-10 holdings as a percentage of reported long equities. While the raw 13F does not disclose derivatives or cash balances, changes in ETF holdings or sector allocations can proxy for shifts in risk posture. For example, an increase in broad-market ETF exposure vs. single-name concentration typically reads as a move toward beta allocation rather than alpha generation. That diagnostic requires access to the filing's holdings table and prior quarters’ 13Fs (SEC EDGAR filings; Investing.com summary, Apr 16, 2026).

Beyond static weights, turnover is the most actionable metric historically. A manager that reports double-digit turnover between sequential 13Fs suggests either an active rebalancing mandate or exposure to higher-frequency signals; by contrast, low turnover signals a buy-and-hold posture. For small managers, turnover can also be a function of capacity constraints — high turnover in sizable names may indicate portfolio reconstitution rather than pure tactical trading. Users of 13F data must therefore normalize turnover by asset class and by the notional scale implied by other public statements or Form ADV disclosures. For further reading on institutional filing analysis, our research hub has process notes and data pipelines at topic.

Sector Implications and Market Comparisons

Form 13Fs provide indirect insight into sector rotation when aggregated across managers; a single filing from a boutique manager like Newfound is unlikely to move broad indices but can reveal relative posture versus benchmarks. Comparing weightings reported on March 31, 2026 with benchmark sector weights (for example, the S&P 500 sector breakdown as of Mar 31, 2026) highlights tactical deviations. If the filing shows overweight in defensive sectors relative to the S&P 500, that could imply risk-off positioning at quarter end; conversely, overweight to cyclical sectors would suggest risk-on. These comparisons should be expressed as percentage-point deviations from the benchmark and interpreted in the context of the manager's disclosed mandate.

A pragmatic comparative exercise is YoY: evaluate the filing versus the same quarter in 2025 to detect structural shifts in strategy. Year-over-year comparisons are less noisy than quarter-to-quarter analyses for detecting mandate drift — e.g., a persistent increase in passive ETF exposure vs. single-name equity holdings across four quarters is evidence of a strategic allocation shift. Historical studies show that short-term 13F signal reliability is limited, but aggregated QoQ and YoY trends across multiple managers produce more robust signals for sector rotation strategies. Institutional clients should combine these 13F-derived signals with higher-frequency indicators such as fund flows, options skews, and credit spreads to form a multi-dimensional view.

Risk Assessment

Relying on a single 13F entails substantial caveats. The filing excludes short positions, many types of derivatives, and cash, and it captures only positions in Section 13(f) securities. That means the true risk posture — particularly for managers that use options, futures, or bespoke swaps — can be materially different from what the 13F discloses. For example, a manager could be long a broad-market ETF on the 13F while holding offsetting index puts not visible in the filing. Institutional consumers should therefore treat 13F data as one input among many and use it to generate hypotheses rather than definitive conclusions.

Counterparty and liquidity risk are additional considerations. If the 13F shows concentration in mid-cap names with low average daily traded volume, exit costs in a stress scenario could be significant. Using the filing to compute measures such as notional position size divided by three-month ADV (average daily volume) provides a rough liquidity stress gauge. These calculations require mapping reported share counts to market prices as of March 31, 2026 — a step that must be done carefully and referenced to reliable market data providers.

Finally, legal and regulatory considerations matter. The 13F is a required public disclosure and does not imply endorsement by regulators; it is a transparency mechanism. Institutional compliance teams often use 13Fs to monitor competitor positioning and to verify that managers are operating within declared mandates. When integrating 13F data into investment decision-making, institutions should maintain audit trails and document assumptions, particularly when using lagged filings to predict near-term flows or trades.

Fazen Markets Perspective

The contrarian insight for allocators reading Newfound Research's April 16, 2026 filing is to prioritize pattern recognition over headline picks. The filing's early submission (16 days after quarter-end) and the basic presence of Section 13(f) securities tell you more about the manager’s reporting infrastructure than about a specific directional view. Historically, boutique managers' 13Fs have produced false positives when interpreted as real-time trade signals; instead, the highest-value use case is trend detection across multiple sequential filings and cross-sectional corroboration with fund flow and derivatives data.

A non-obvious read is to treat the 13F as a proxy for capacity and operational readiness. Early, clean filings suggest solid middle-office processes and lower operational risk — attributes that matter for counterparties and allocators assessing execution risk. In contrast, late or corrected filings have historically tracked with higher operational incidents. While these operational factors do not translate one-for-one into alpha, they materially affect implementation risk and therefore the realized return of any strategy overlaying a manager's exposures.

For institutional investors, the practical application is to fold 13F-derived signals into a weighted decision matrix rather than treating them as binary triggers. Use the filing to flag candidates for further diligence — i.e., if a manager shows persistent sector divergence, escalate to direct engagement and request higher-frequency reporting or a composite performance series. That approach preserves the value of the 13F as a regulatory data point while avoiding overfitting to lagged disclosure noise.

Outlook

Looking ahead, incremental value from individual 13F filings will continue to reside in their use as inputs to multi-manager, multi-data-source analytics rather than as standalone trading signals. The April 16, 2026 Newfound Research filing is one data point among many; institutional investors and allocators should expect more meaningful inference when combining sequential 13Fs with real-time market metrics such as fund flows, options order flow, and liquidity snapshots. The productization of 13F analytics — automated ingestion, normalization, and sequential comparison — will further reduce the marginal cost of extracting insight from these filings.

Regulatory evolution or changes in reporting thresholds could alter the utility of 13Fs over time. Currently, the $100 million reporting threshold and the 45-day filing window remain intact (SEC.gov), which preserves 13Fs as a stable, if lagged, source of transparency. For allocators seeking to operationalize 13F analysis, investing in normalized historical 13F databases and integrating those with execution-cost models will generate the highest signal-to-noise ratio.

Bottom Line

Newfound Research’s Form 13F filed April 16, 2026 is a timely, early-quarter snapshot (positions as of Mar 31, 2026; filed 16 days later) that should be used to detect pattern and process signals rather than as a short-term trading catalyst. Institutional practitioners will extract the most value by combining sequential 13F analysis with higher-frequency market data and direct manager engagement.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.